Seminars in Nuclear Medicine
Volume 38, Issue 3 , Pages 199-208, May 2008

Positron Emission Tomography/Magnetic Resonance Imaging: The Next Generation of Multimodality Imaging?

  • Bernd J. Pichler, PhD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Bernd J. Pichler, PhD, Laboratory for Preclinical Imaging and Imaging Technology of the Werner Siemens Foundation, Department of Radiology, University of Tübingen, Röntgenweg 13, 72076 Tübingen, Germany.
  • ,
  • Hans F. Wehrl, MS
  • ,
  • Armin Kolb, BS
  • ,
  • Martin S. Judenhofer, BS

Laboratory for Preclinical Imaging and Imaging Technology of the Werner Siemens Foundation, Department of Radiology, University of Tübingen, Tübingen, Germany.

Multimodal imaging is now well-established in routine clinical practice. Especially in the field of nuclear medicine, new positron emission tomography (PET) installations comprise almost exclusively combined PET/computed tomography (CT) scanners rather than PET-only systems. However, PET/CT has certain notable shortcomings, including the inability to perform simultaneous data acquisition and the significant radiation dose to the patient contributed by CT. Magnetic resonance imaging (MRI) offers, compared with CT, better contrast among soft tissues as well as functional-imaging capabilities. Therefore, the combination of PET with MRI provides many advantages that go far beyond simply combining functional PET information with structural MRI information. Many technical challenges, including possible interference between these modalities, have to be solved when combining PET and MRI, and various approaches have been adapted to resolving these issues. Here, we present an overview of current working prototypes of combined PET/MRI scanners from different groups. In addition, besides PET/MRI images of mice, the first such images of a rat acquired with the first commercial clinical PET/MRI scanner, are presented. The combination of PET and MRI is a promising tool in preclinical research and will certainly progress to clinical application.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0001-2998(08)00024-X

doi:10.1053/j.semnuclmed.2008.02.001

Seminars in Nuclear Medicine
Volume 38, Issue 3 , Pages 199-208, May 2008